Eric Joseph Daniels - 21 Oct 2021 Form 4/A - Amendment Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Chief Development Officer
Signature
/s/ Sarah Romano, Attorney-in-Fact*
Issuer symbol
KPRX
Transactions as of
21 Oct 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
22 Nov 2021, 15:31:09 UTC
Date Of Original Report
10 Nov 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Award +9,520 9,520 21 Oct 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were omitted from the Reporting Person's Form 4 filed on November 10, 2021.
F2 Received by the Reporting Person in connection with the acquisition by the issuer of all of the outstanding securities of Bayon Therapeutics, Inc. on October 21, 2021.